Delhi government on Thursday announced that the precautionary or the booster COVID-19 dose will be available for free to all eligible beneficiaries aged between 18 and 59 years in all government vaccination centres. ...
Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the coronavirus infection than mRNA vaccines like Pfizer and Moderna. ...
As some countries are presently reporting higher COVID-19 cases, Chief Executive Officer of Serum Institute of India (SII) Adar Poonawalla on Tuesday said that India is better prepared to face it now than it was in 2020. ...
Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccin ...
The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Se ...
Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose. ...
Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year. ...
